Is the price fair?
What GMAB's price assumes
Genmab A/S did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 0.04× revenue.
0.04
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.04
Price / book · as of 2024-H2
Details›
- Price / book2024-H2
- 0.04
- Market capitalisation
- $15.5B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.